Mitsuo Sawai
Amministratore Delegato presso SAWAI GROUP HOLDINGS CO., LTD.
Patrimonio netto: 40 M $ in data 30/04/2024
Posizioni attive di Mitsuo Sawai
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Amministratore Delegato | 01/04/2021 | - |
| Presidente | 01/04/2021 | - | |
Sawai Pharmaceutical Co., Ltd.
 Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Presidente | 23/06/2020 | - |
| Direttore/Membro del Consiglio | 01/06/2000 | 23/06/2020 | |
| Presidente | 01/06/2008 | 23/06/2020 | |
| Vendite & Marketing | 01/06/2000 | 01/06/2008 |
Storia della carriera di Mitsuo Sawai
Statistiche
Distribuzione geografica
| Giappone | 3 |
Posizioni
| Chairman | 2 |
| Director/Board Member | 1 |
| President | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
- Borsa valori
- Insiders
- Mitsuo Sawai
- Esperienza
